Page last updated: 2024-11-04

sulfapyridine and Acquired Form of Epidermolysis Bullosa

sulfapyridine has been researched along with Acquired Form of Epidermolysis Bullosa in 1 studies

Sulfapyridine: Antibacterial, potentially toxic, used to treat certain skin diseases.
sulfapyridine : A sulfonamide consisting of pyridine with a 4-aminobenzenesulfonamido group at the 2-position.

Research Excerpts

ExcerptRelevanceReference
"Epidermolysis bullosa acquisita is a rare and debilitating autoimmune mucocutaneous blistering disease caused by autoantibodies directed against type VII collagen or anchoring fibrils in the subepidermal basement membrane zone."2.47Management of epidermolysis bullosa acquisita. ( Intong, LR; Murrell, DF, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Intong, LR1
Murrell, DF1

Reviews

1 review available for sulfapyridine and Acquired Form of Epidermolysis Bullosa

ArticleYear
Management of epidermolysis bullosa acquisita.
    Dermatologic clinics, 2011, Volume: 29, Issue:4

    Topics: Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Autoimmune Diseases; Chronic Disease; Colchi

2011